Add BrightSurf on Google Email

Nationwide Safety Program associated with 65% reduction in hospital-onset MRSA bloodstream infections

A nationwide safety program significantly reduced hospital-onset MRSA infections by 65% in participating US hospitals. The program implemented evidence-based infection prevention strategies, including hand hygiene, environmental cleaning, and device-associated infection prevention, and engaged front-line workers across disciplines.

SourceJohns Hopkins Medicine·JournalJAMA Network Open·DateSep 14, 2026

How rituximab affects T cells in kidney disease

Researchers found that rituximab treatment increases mitochondrial energy production and reduces cell stress in T cells, leading to improved response rates in patients with nephrotic syndrome. This discovery could help predict patient response to treatment and identify suitable candidates for early remission.

SourceNagoya University·JournaliScience·TypeObservational study·DateSep 10, 2026

MIT engineers find a precise way to grow artificial blood vessels

Researchers at MIT have created a precise way to engineer artificial blood vessels by mechanically stretching and pulling a "blood vessel on a chip". The new method, reported in the Proceedings of the National Academy of Sciences, enables controlled sprouting of new vessels and programming of their growth patterns.

SourceMassachusetts Institute of Technology·JournalProceedings of the National Academy of Sciences·DateJul 15, 2026

The 700-million-year history of our blood cells

A team of researchers at Kyoto University has reconstructed the family tree of blood cells over a 700-million-year span, revealing their evolutionary history. They found that early blood cells emerged around the same time as multicellular animals and were macrophage-like.

SourceKyoto University·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateMay 25, 2026

Understanding how oxygen is delivered to tissues at the microscopic level

Researchers at Kyushu University developed a new mathematical model that simulates oxygen transport by red blood cells through tiny blood vessels and their delivery to surrounding tissues. The findings show that RBCs can naturally adjust the amount of oxygen released based on local requirements.

SourceKyushu University·JournalInternational Journal of Heat and Mass Transfer·TypeComputational simulation/modeling·DateApr 28, 2026

Researchers create an injectable particle to make surgery safer for infants

A team of researchers at North Carolina State University has created an injectable microgel called B-knob triggered microgels (BK-TriGs) that can help reduce bleeding in infants during surgery. The microgel works by mimicking the mechanical properties of natural platelets, which helps to create fibrin networks and stanch bleeding.

SourceNorth Carolina State University·JournalScience Advances·TypeExperimental study·DateApr 3, 2026

NUS Medicine scientists identify potential therapy and diagnostic markers for cerebral malaria

Researchers found that methylene blue can reverse brain damage caused by cerebral malaria and identified a nine-gene blood signature to diagnose the disease. The study's findings offer new clues on immune processes involved in brain injury and suggest potential for early intervention and clearer treatment decisions.

Decoding the T-cell burst: Signature genes that predict T-cell expansion in cancer immunotherapy

Researchers at Tokyo University of Science identified genes that predict CD8+ T cell expansion in cancer immunotherapy. A 'signature gene set' or 'expansion signature' was found to identify primed T cells for growth, predicting treatment response and offering a potential guide for new therapies.

SourceTokyo University of Science·JournalNature Communications·TypeExperimental study·DateOct 21, 2025

New lab-grown human embryo model produces blood cells

Researchers at the University of Cambridge have developed a new lab-grown human embryo model that replicates early human development, including the production of blood stem cells. The 'hematoids' model mimics the natural developmental process, offering potential medical advances in screening drugs and studying blood disorders.

SourceUniversity of Cambridge·JournalCell Reports·TypeExperimental study·DateOct 13, 2025

UCLA scientists advance gene therapy for deadly blood disorder alpha thalassemia major

A UCLA research team led by Dr. Donald Kohn has developed a one-time stem cell gene therapy treatment for alpha thalassemia major that could be curative. The therapy involves adding the missing alpha-globin gene to patient cells using a viral vector, enabling them to produce functional hemoglobin.

SourceUniversity of California - Los Angeles·JournalCell Reports Medicine·TypeExperimental study·DateSep 17, 2025

Nanoscale images of a blood clotting protein complex reveal a secret to the clotting chain reaction

Scientists have solved a mystery vexing biological chemists for over 30 years by determining 3D structures of blood clotting proteins using cryo-electron microscopy. The discovery sheds light on how the cascade of events that leads to blood clotting is triggered, with potential implications for anticoagulant drugs like Warfarin.

Research findings offer new insight into blood thinners and bone builders

A team of Virginia Tech researchers has discovered new insights into blood thinners and bone builders, heparin. The findings may lead to designing safer and more reliable heparin therapies. Heparin's molecular composition affects its ability to bind calcium, influencing its effectiveness in biomineralization and blood clotting.

SourceVirginia Tech·JournalProceedings of the National Academy of Sciences·DateSep 4, 2025

Centuries after discovery, red blood cells still hold surprises

Researchers at University of Pennsylvania discover red blood cells contribute to clot contraction, shrinking and stabilizing blood clots. The finding opens door to new strategies for studying and treating clotting disorders, such as excessive bleeding or dangerous clots like those seen in strokes.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalBlood Advances·TypeExperimental study·DateAug 6, 2025

Assessing blood stem cell quality by analyzing cell behavior in real time

A study from The University of Tokyo predicts HSC quality based on real-time cellular behavior using advanced imaging technology and machine learning. The researchers discovered previously hidden diversity within HSC populations and found that kinetic features could predict the expression levels of a key gene related to 'stemness'.

SourceThe Institute of Medical Science, The University of Tokyo·JournalNature Communications·TypeExperimental study·DateJul 29, 2025

A Journal of Environmental Sciences study reveals that metal-organic frameworks may be toxic

A study reveals that metal-organic frameworks (MOFs) can be toxic to mice, causing disruptions in blood cell formation and immune balance. The researchers found that the MOFs suppressed production of certain cells but also triggered a rebound effect, leading to increased inflammation.

SourceEditorial Office of Journal of Environmental Sciences·JournalJournal of Environmental Sciences·TypeExperimental study·DateJun 24, 2025

A game-changing way to treat stroke

Researchers at Stanford University developed a new technique called the milli-spinner thrombectomy that significantly improves success rates in treating strokes and other clot-related diseases. The milli-spinner can reduce clots to as little as 5% of their original volume, making it a promising tool for improving patient outcomes.

SourceStanford University·JournalNature·DateJun 4, 2025

Modification makes immunotherapy for blood cancer even more effective

Researchers at A.C.Camargo Cancer Center developed a more powerful version of CAR-T cells by inhibiting the epigenetic alterations that made them inefficient against non-Hodgkin's lymphoma and acute lymphoblastic leukemia. This modification resulted in improved treatment efficacy, tumor elimination, and reduced side effects.

A step closer to the confident production of blood stem cells for regenerative medicine

A team of scientists has identified seven genes that can transform embryonic stem cells into blood precursor cells, paving the way for a new era in regenerative medicine. The research, published in the journal Blood, uses an unbiased genome-wide screen to uncover the genes involved in hematopoietic stem cell fate.

SourceJosep Carreras Leukaemia Research Institute·JournalBlood·TypeExperimental study·DateMay 16, 2025

Blood type a identified as potential breast cancer risk factor

A systematic review and meta-analysis found that individuals with blood type A have a significantly higher risk of developing breast cancer compared to those with blood type O. The research, which pooled data from over 13,000 breast cancer patients and 717,000 controls, suggests an 18% increased risk associated with blood type A.

SourceImpact Journals LLC·JournalOncotarget·TypeMeta-analysis·DateMay 14, 2025

'Black box' of stem cell transplants opened in world-first blood study

Researchers tracked the long-term dynamics of transplanted stem cells in patients' bodies up to three decades post-transplant. They found that younger donors produce more vital stem cells, while older donors experience reduced immunity and higher relapse risk. The study provides new insights into donor selection and transplant success.

SourceWellcome Trust Sanger Institute·JournalNature·TypeObservational study·DateOct 30, 2024

Survival gap eliminated for Black cord blood recipients with blood cancers, study finds

A retrospective analysis of over 2,600 patients found that Black children were more likely to suffer severe graft-versus-host disease but overall survival rates improved across all racial groups. The study suggests that cord blood transplants are a vital lifeline for many patients and improve care for those without a matched donor.

SourceUniversity of Virginia Health System·JournalTransplantation and Cellular Therapy·DateOct 1, 2024

Groundbreaking Crnic Institute study discovers differences in oxygen physiology in people with Down syndrome

Researchers from the Linda Crnic Institute for Down Syndrome identified lower oxygen availability and dysregulated red blood cell function in individuals with Down syndrome. The study highlights potential targets for effective medical interventions to improve oxygen physiology in this population.

SourceUniversity of Colorado Anschutz Medical Campus·JournalCell Reports·TypeExperimental study·DateAug 15, 2024

Genes driving age-related blood cell mutations uncovered

Scientists have discovered 17 new genes involved in clonal haematopoiesis, a process associated with ageing linked to increased risks of blood cancers. The findings highlight the clinical significance of these genes in driving mutant blood cell clones, offering new avenues for studying disease development and promoting healthier ageing.

SourceWellcome Trust Sanger Institute·JournalNature Genetics·TypeObservational study·DateMay 14, 2024

Breakthrough discovery will improve medical monitoring, preventive care for elephants

Researchers at San Diego Zoo Wildlife Alliance have made a groundbreaking discovery that establishes individual baseline values for African elephant blood cell counts, enabling earlier detection and intervention of clinical EEHV infection. This study provides a tool for elephant care facilities to improve preventive medicine and lifesa...

SourceSan Diego Zoo Wildlife Alliance·JournalJournal of Zoo and Wildlife Medicine·TypeExperimental study·DateMar 5, 2024